---
title: "Chuanhuan Technology released its first-quarter performance, with a net profit attributable to the parent company of 46.4356 million yuan, an increase of 5.06%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236826783.md"
description: "According to the Zhitong Finance APP, Chuanhuan Technology released its first quarter report for 2025, with operating revenue of 316 million yuan, a year-on-year increase of 5.60%. The net profit attributable to shareholders of the listed company was 46.4356 million yuan, a year-on-year increase of 5.06%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 44.1863 million yuan, a year-on-year increase of 6.70%. The basic earnings per share were 0.2141 yuan"
datetime: "2025-04-21T15:33:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236826783.md)
  - [en](https://longbridge.com/en/news/236826783.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236826783.md)
generator: "portal-rs"
---

# Chuanhuan Technology released its first-quarter performance, with a net profit attributable to the parent company of 46.4356 million yuan, an increase of 5.06%

According to the Zhitong Finance APP, Chuanhuan Technology (300547.SZ) released its first-quarter report for 2025, with operating revenue of 316 million yuan, a year-on-year increase of 5.60%. The net profit attributable to shareholders of the listed company was 46.4356 million yuan, a year-on-year increase of 5.06%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 44.1863 million yuan, a year-on-year increase of 6.70%. The basic earnings per share were 0.2141 yuan

### Related Stocks

- [300547.CN](https://longbridge.com/en/quote/300547.CN.md)

## Related News & Research

- [FCA bans wealth manager trio behind £35.5m investor visa scam](https://longbridge.com/en/news/297037200.md)
- [RUBBER-Japan futures rise on supply concerns in top producing regions](https://longbridge.com/en/news/297141554.md)
- [CytoNiche Expands U.S. FDA Regulatory Filings for 3D RecomTrix Recombinant Collagen Microcarriers](https://longbridge.com/en/news/297358302.md)
- [Oncopeptides publishes transcript of Q2 2026 earnings call](https://longbridge.com/en/news/297142294.md)
- [Mark Walter's TWG is working with regulators, says 'no fraud'](https://longbridge.com/en/news/297064154.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**